NCT03741088View on ClinicalTrials.gov

Study to Evaluate VORTX Rx (Theresa)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 21, 2018

Primary Completion Date

May 15, 2019

Study Completion Date

July 17, 2019

Conditions
Carcinoma, HepatocellularLiver Metastases
Interventions
DEVICE

VORTX Rx treatment

Cavitation-based cellular destruction using focused ultrasound

Trial Locations (3)

08950

Clinica Diagonal, Esplugues de Llobregat

08221

Hospital universitario Mutua Terrassa, Terrassa

08035

Hospital Universitario Vall d´Hebrón, Barcelona

Sponsors

Lead Sponsor

HistoSonics, Inc.
All Listed Sponsors
lead

HistoSonics, Inc.

INDUSTRY

NCT03741088 - Study to Evaluate VORTX Rx (Theresa) | Biotech Hunter | Biotech Hunter